Managing the ‘Urgency’ of an Overactive Bladder
Overactive bladder (OAB) is defined as a syndrome of urinary urgency usually accompanied by increased
daytime urinary frequency and nocturia in the absence of infection and localised pathological causal factors with or without urinary incontinence (UI). Clinical trial results have demonstrated that
mirabegron, a selective β3-adrenoceptor agonist, offers substantial clinical efficacy and good
adherence rates over 12 months for managing the symptoms associated with overactive bladder.
